GSK3B and cancer: Given the described role of GSK3B-mediated phosphorylation of T334 in facilitating HR repair regardless of BRCA1 status (Figure 6G), we asked whether interruption of T334 phosphorylation would sensitize cancer cells to the PARPi Olaparib.